Back to results
US 2020/0138748 A1Published application
Composition and method for aiding sleep
AssigneeSequential Medicine Limited
InventorLan Bo CHEN
Life of this patent
Estimating the term…
Abstract
Disclosed is a controlled-release formulation for treating disturbed sleep or insomnia in a subject. The formulation is formulated to release diphenhydramine HCl and a sleep aid in sequence at two stages.
Claims13
A controlled-release formulation, comprising diphenhydramine HCl and a sleep aid which is zolpidem tartrate or lorazepam, wherein the formulation is formulated for a first stage release of the diphenhydramine HCl immediately after administering to a subject, and a second stage release of the sleep aid that starts 0.5-6 hours after initiation of the first stage.
Dependencies are inferred from the claim text.